REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/05/2026
Voltar para busca
Dado oficial do USPTO
HEMO+
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079286967Classe
5, 6, 9, 10, 11, 37, 41, 42
Pedido
79286967
Registro
6344136
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
12/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 6, 9, 10, 11, 37, 41, 42
Data de depósito
20/12/2019
Data de registro
11/05/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/05/2021
Última transação
12/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CH
Examinador
MALYSZEK, KIMBERLY RAY
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "HEMO" with a cross with a drop shadow to the right of the wording.
Titulares e representantes
Titulares
HEMO PLUS S?rl
Representantes
Duane M. Byers Nixon & Vanderhye PC
Classificação técnica
Classes Nice
Classe 5Classe 6Classe 9Classe 10Classe 11Classe 37Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Concentrated pharmaceutical products for hemodialysis treatmentpackaged in drums and containersdiluted products for hemodialysis treatment; pharmaceutical products for hemodialysis and other treatments packaged in flexible bags or glass ampoulesespecially solid solutes such as glucose for rehydration and calorie intake; glycocol as a solution for irrigation of blood; mannitol as a solution for irrigation of blood; pharmaceutical preparationglucose/NaCl mixfor rehydration; pharmaceutical preparationRinger's lactate solution for hydroelectric rebalancehypovolemiamaintaining acid-base balance; pharmaceutical preparationsodium chloride for rehydration and hydroelectric rebalancewater for injection (WFI) for injectable preparations in the nature of irrigation solution for irrigation of blood; pharmaceutical preparationgeneric medical preparationsin the nature of ciprofloxacin as an antibiotic; pharmaceutical preparationfluconazole as an antifungalketoprofen as an analgesic and anti-inflammatory; pharmaceutical preparationlevobupivacaine as an anesthetic; pharmaceutical preparationlevofloxacin as an antibiotic; pharmaceutical preparationmetronidazole as an antibiotic and antiparasitic; pharmaceutical preparationmorphine hydrochloride as an analgesic; pharmaceutical preparationmoxifloxacin as an antibiotic; pharmaceutical preparationofloxacin as an antibiotic; pharmaceutical preparationparacetamol as an analgesic and antipyreticropivacaine Hcl as an anaesthetic; pharmaceutical preparationtirofiban as an anticoagulant; pharmaceutical preparationzoledronic acid for patients suffering from osteoporosis; pharmaceutical preparationinjectable ampoules containing medicated preparationsquinine as an antimalarialpotassium chloride for hypokalemiahydroelectric rebalancing; pharmaceutical preparationsodium chloride for hydroelectric rebalancing; pharmaceutical preparationwater for injection (WFI) as a vehicle for parenteral administration; pharmaceutical preparationmagnesium sulfate for hypokalemiaeclampsiatorsade de pointehypocalcemia; pharmaceutical preparationsodium bicarbonate for metabolic acidosiscardiovascular arrest; pharmaceutical preparationglucose for carbohydrate calorie intake
Classe 6
Prefabricated buildings of metal and prefabricated modular metal structures for creating premises for installation of manufacturing units for drugsconcentrated products for hemodialysis treatment and care premises for hemodialysis treatment provided to patients suffering from kidney disorders
Classe 9
Data processing equipment and computers for use in the medical field; data processing equipment and data processing machines for use in the medical field
Classe 10
Hemodialysis machines; control instruments and apparatus in the medical fieldcontrollers for medical fluid injectorscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; measuring or testing instruments and machines in the medical fieldwearable monitors used to measure biometric data for medical useblood testing apparatus
Classe 11
Waste disposal incinerators; clean rooms; clean-room installations; apparatus and machines for purifying air and water in the medical field; devices for cooling air and water in the medical fieldwater coolersevaporative air coolersair conditioning apparatus
Classe 37
Installationmaintenance and repair of installationsequipment and apparatus in the medical fieldHemodialysis machinescontrol instruments and apparatus in the medical fieldcontrollers for medical fluid injectorscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatusmeasuring or testing instruments and machines in the medical fieldwearable monitors used to measure biometric data for medical useblood testing apparatus; installation of clean room systems
Classe 41
Educational and training servicesnamely providing classesseminarsworkshopsteachingdistance learning in the medical fieldsnamely in the field of hemodialysis; vocational retraining in the medical field; personalized coaching as a training service and as an educational service in the medical field; information relating to education; training for staff developmentteam building and organizational development in the medical field
Classe 42
Technical scientific research and manufacturing project studies in the medical field; technical scientific research and manufacturing project studies and scientific research projects in the medical field; technical scientific research and manufacturing project planning; quality control of products and services in the medical field
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/12/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/10/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
28/08/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
27/08/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/02/2021
PUBO
PUBLISHED FOR OPPOSITION
23/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/02/2021
ALIE
ASSIGNED TO LIE
19/01/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
19/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
19/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/01/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
20/10/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/10/2020
RFNT
REFUSAL PROCESSED BY IB
01/08/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
24/07/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/07/2020
RFRR
REFUSAL PROCESSED BY MPU
15/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/06/2020
CNRT
NON-FINAL ACTION WRITTEN
08/06/2020
DOCK
ASSIGNED TO EXAMINER
08/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEMO+ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.